BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7637753)

  • 1. Epstein-Barr virus--increasing evidence of a link to carcinoma.
    Kieff E
    N Engl J Med; 1995 Sep; 333(11):724-6. PubMed ID: 7637753
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus and nasopharyngeal cancer.
    Schuster V; Pukrop T
    N Engl J Med; 1996 Jan; 334(2):122-3. PubMed ID: 8531953
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Raab-Traub N
    Infect Agents Dis; 1992 Aug; 1(4):173-84. PubMed ID: 1365543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
    Pathmanathan R; Prasad U; Sadler R; Flynn K; Raab-Traub N
    N Engl J Med; 1995 Sep; 333(11):693-8. PubMed ID: 7637746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus and nasopharyngeal cancer.
    Meisler AI
    N Engl J Med; 1996 Jan; 334(2):122; author reply 122-3. PubMed ID: 8531952
    [No Abstract]   [Full Text] [Related]  

  • 6. A new lytic antibody, 7D6, detects Epstein-Barr virus dUTPase in nonkeratinizing undifferentiated nasopharyngeal carcinomas.
    Nicholls JM; Sommer P; Kremmer E; Ong KS; Fung K; Lee JM; Ng MH; Grässer FA
    Lab Invest; 1998 Aug; 78(8):1031-2. PubMed ID: 9714190
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neck lymph node metastases of unknown origin: nasopharyngeal origin and EBV (Epstein-Barr virus)].
    Plaza G; Santón A; Fogué L; Bellas C; Martínez Vidal A
    Acta Otorrinolaringol Esp; 1999; 50(8):623-9. PubMed ID: 10619898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.
    Niedobitek G; Agathanggelou A; Nicholls JM
    Semin Cancer Biol; 1996 Aug; 7(4):165-74. PubMed ID: 8946600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas.
    Murray PG; Niedobitek G; Kremmer E; Grässer F; Reynolds GM; Cruchley A; Williams DM; Müller-Lantzsch N; Young LS
    J Pathol; 1996 Jan; 178(1):44-7. PubMed ID: 8778314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
    You S; Yao K; Cao Y
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):23-6. PubMed ID: 8732106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies.
    Busson P; Keryer C; Ooka T; Corbex M
    Trends Microbiol; 2004 Aug; 12(8):356-60. PubMed ID: 15276610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma.
    Heussinger N; Büttner M; Ott G; Brachtel E; Pilch BZ; Kremmer E; Niedobitek G
    J Pathol; 2004 Jun; 203(2):696-9. PubMed ID: 15141385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion, Xho1 polymorphism and evidence of dual infections.
    Tan EL; Peh SC; Sam CK
    J Med Virol; 2003 Feb; 69(2):251-7. PubMed ID: 12683415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability in Epstein-Barr virus associated with nasopharyngeal carcinoma.
    Tanunyutthawongese C; Sriuranpong V; Kerekhanjanarong V; Changchup B; Yenrudi S; Supiyaphun P; Voravud N; Mutirangura A
    J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S71-7. PubMed ID: 9071070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epstein-Barr, hepatitis B and hepatitis C virus infections and their oncogenic potentials].
    Jovanović J; Brkić S; Klasnja B; Fabri M
    Med Pregl; 1997; 50(11-12):499-504. PubMed ID: 9471511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus infection in non-carcinomatous gastric epithelium.
    Yanai H; Takada K; Shimizu N; Mizugaki Y; Tada M; Okita K
    J Pathol; 1997 Nov; 183(3):293-8. PubMed ID: 9422984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus infection as co-factor in cervical carcinogenesis?
    van den Brule AJ; Walboomers JM; Meijer CJ
    J Pathol; 1995 Jul; 176(3):219-20. PubMed ID: 7674083
    [No Abstract]   [Full Text] [Related]  

  • 19. ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus.
    Nadala EC; Tan TM; Wong HM; Ting RC
    J Med Virol; 1996 Sep; 50(1):93-6. PubMed ID: 8890046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical involvement of undifferentiated carcinomas of the nasopharyngeal type. Apropos of 3 cases].
    Le Roy A; Honigman I; Chevalier E; Hazan A; Bodiguel V; Adotti F; Peytral C
    Ann Otolaryngol Chir Cervicofac; 1998 Nov; 115(5):288-92. PubMed ID: 9881177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.